A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure
Status:
Terminated
Trial end date:
2020-04-08
Target enrollment:
Participant gender:
Summary
The main objective of the study is investigate the effect of escalating doses of oral
tyramine on systolic blood pressure (SBP) at baseline and following an oral treatment with BI
1467335 up to 39 days at a low or high dose once daily compared to placebo and phenelzine
(Nardil®) as positive control.